The MAG meets quarterly to discuss high level medicines access issues and is a sub-group of the Ministerial Industry Strategy Group. It brings together industry with relevant government departments, senior health stakeholders from NICE, the National Commissioning Board and a representative from a patient group.
Steve takes on the co-chairmanship of the MAG at an important time for industry, with the need to improve access to innovative medicines and treatments within the UK.
He will co-chair the group with Giles Denham, Director of the Medicines, Pharmacy & Industry Group at the Department of Health and will replace Matthew Speers, Managing Director of UCB Pharma Ltd, British and Irish Isles.
Previously, Steve played a key role for industry in the development and publication of the National Metrics Report, which evaluated NICE approved medicines and their usage and uptake within the NHS, through his role as co-chair of the Metrics Oversight Group.